<p>The vascular function is increased in tumors of RT<sup>pos</sup>SG<sup>ko</sup> versus RT<sup>pos</sup>SG<sup>wt</sup> mice. 15 week RT<sup>pos</sup>SG<sup>wt</sup> (a) and RT<sup>pos</sup>SG<sup>ko</sup> (b) mice were perfused with FITC-lectin, which was introduced to the circulation prior to sacrifice of the animals and excision of the pancreas. Tumor sections were stained for the endothelial marker CD31 (red), the localization of which was compared to lectin (green) that had immobilized on the luminal side of endothelial cells in perfused vessels. The ratio between immobilized lectin and CD31 staining was calculated to determine the fraction of perfused, and thus functional vessels (c). Each data point in represents an individual anim...
<p><b>A.</b> Left: <i>in vivo</i> tumor vasculature visualized by intracardiac injection of FITC lec...
<p>PC-3-tumors, LNs and RNs were excised, cut in 100 µm sections and stained with anti-CD31 antibody...
<p>Stereology of CD31-positive vessels in CT26 carcinomas grown in integrin β<sub>3</sub>-deficient ...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>(A) Representative photographs of 80 µm thick tumor sections from 16K-Ad- and Null-Ad-inoculated ...
<p>A: Tumor sections from the legs of WT and <i>VASH1 (−/−)</i> mice were immunostained for CD31 and...
<p>(A, B) Immunohistochemical staining of tumor tissue from HRG<sup>+/+</sup> and HRG<sup>−/−</sup> ...
<p>(A) Vascular area (as a percent of the tumor) and (B) median vessel size in the tumors of animals...
<p>Observations in living mice using intravital microscopy (A, B, C: red – functional blood vessels;...
<p>Immunohistochemical detection of endothelial CD31 (A, D, green) and VEGFR-2 (B, E, red) of microv...
<p>A549 tumor-bearing mice were treated with rh-endostatin (5 mg/kg, s.c.) for consecutive 7 days wi...
<p>Sections of tumors recovered from mice, untreated control and treated with either HB-19 or 5-FU (...
<p>A549 tumor-bearing mice were treated with rh-endostatin (5 mg/kg, s.c.) for consecutive 7 days wi...
<p>LLC tumor-bearing C57BL6/J mice were systemically treated with control saline or with 2.5 mg/kg/d...
<p>(A): Representative images of Lyve-1 positive-vessels at two different magnifications in VEGF-C e...
<p><b>A.</b> Left: <i>in vivo</i> tumor vasculature visualized by intracardiac injection of FITC lec...
<p>PC-3-tumors, LNs and RNs were excised, cut in 100 µm sections and stained with anti-CD31 antibody...
<p>Stereology of CD31-positive vessels in CT26 carcinomas grown in integrin β<sub>3</sub>-deficient ...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>(A) Representative photographs of 80 µm thick tumor sections from 16K-Ad- and Null-Ad-inoculated ...
<p>A: Tumor sections from the legs of WT and <i>VASH1 (−/−)</i> mice were immunostained for CD31 and...
<p>(A, B) Immunohistochemical staining of tumor tissue from HRG<sup>+/+</sup> and HRG<sup>−/−</sup> ...
<p>(A) Vascular area (as a percent of the tumor) and (B) median vessel size in the tumors of animals...
<p>Observations in living mice using intravital microscopy (A, B, C: red – functional blood vessels;...
<p>Immunohistochemical detection of endothelial CD31 (A, D, green) and VEGFR-2 (B, E, red) of microv...
<p>A549 tumor-bearing mice were treated with rh-endostatin (5 mg/kg, s.c.) for consecutive 7 days wi...
<p>Sections of tumors recovered from mice, untreated control and treated with either HB-19 or 5-FU (...
<p>A549 tumor-bearing mice were treated with rh-endostatin (5 mg/kg, s.c.) for consecutive 7 days wi...
<p>LLC tumor-bearing C57BL6/J mice were systemically treated with control saline or with 2.5 mg/kg/d...
<p>(A): Representative images of Lyve-1 positive-vessels at two different magnifications in VEGF-C e...
<p><b>A.</b> Left: <i>in vivo</i> tumor vasculature visualized by intracardiac injection of FITC lec...
<p>PC-3-tumors, LNs and RNs were excised, cut in 100 µm sections and stained with anti-CD31 antibody...
<p>Stereology of CD31-positive vessels in CT26 carcinomas grown in integrin β<sub>3</sub>-deficient ...